Interventional Oncology Treatments for Liver Cancer

This information is useful for adults and older adults
A senior man with glasses is relaxing with a newspaper.
Why Yale Medicine?
  • Our Department of Radiology & Biomedical Imaging at Yale Medicine is one of the best departments of its kind nationally.
  • Patients have access to clinical trials for treatments that can improve outcomes -- and aren't available elsewhere.
  • Researchers here are studying new, effective ways to deliver chemotherapy and radiation to the liver.

Liver cancer incidence is rising, for a variety of reasons including viral infections and lifestyle. Primary liver cancer is a challenging condition to diagnose and treat, in part because many cases of liver cancer are diagnosed when the condition is already advanced and surgical treatment no longer offers a cure.

That is when Yale Medicine becomes involved. The doctors at Yale Interventional Radiology and Interventional Oncology at Smilow use cutting-edge image guidance for precise, minimally invasive treatments of liver cancer. According to Kevin Kim, MD, chief of Yale Medicine Interventional Radiology and Interventional Oncology at Smilow Cancer Hospital, "The majority of patients with liver cancer benefit, in terms of overall survival and quality of life, from precision-targeted interventional treatments."

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.